Drug profile · INN
lenacapavir sodium
SUNLENCA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lenacapavir sodium (SUNLENCA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN lenacapavir sodium
Brand SUNLENCA
Route SUBCUTANEOUS
Formulation SOLUTION
Frequently asked questions
What is lenacapavir sodium?
lenacapavir sodium (SUNLENCA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for lenacapavir sodium?
SUNLENCA is a marketed brand name for lenacapavir sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lenacapavir sodium?
lenacapavir sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.